No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Alemtuzumab / therapeutic use*
-
Etanercept / therapeutic use
-
Female
-
Humans
-
Immunologic Factors / therapeutic use*
-
Immunosuppressive Agents / therapeutic use
-
Leukoencephalopathy, Progressive Multifocal / chemically induced*
-
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
-
Natalizumab / adverse effects*
-
Plasma Exchange
-
Rituximab / therapeutic use*
Substances
-
Immunologic Factors
-
Immunosuppressive Agents
-
Natalizumab
-
Alemtuzumab
-
Rituximab
-
Etanercept